SABPA Science & Technology Forum IX:

New Trend in Drug Development: Companion Diagnostics

When:              March 19, 2011 (Saturday) 8:30am – 12:30 pm

Where:             Institute of Americas, UCSD

Organizer:        SABPA

Registration:    https://www.123signup.com/register?id=vcycz

            $20 for online registration, $10 for students and post-docs                  

                          $40 for on-site registration, online registration ends March 16, 2009

Companion diagnostics, which looks for genetic, protein, or gene expression markers to predict whether a drug works in someone or causes adverse effect, has emerged into an exciting new trend over the last few years.   With the cost and hurdle to get a new drug approved getting higher and higher, more and more pharma companies begin to explore using companion test to develop safer and more effective drugs.  The value of companion diagnostic tests has already been proven by a number of marketed products, such as Hercep-Test for Herceptin and K-RAS mutation test for Erbutux and Vectibix.  Despite the proven successes and wider awareness of companion diagnostic, pharma companies still move slowly in adopting the new paradigm to co-develop new drugs along with the companion tests.  The regulatory hurdles, viable business strategies, physician acceptances, insurance coverage, and many other barriers remain unsettled for this young filed.  At the SABPA Sci&Tech forum IX, we invite a number of opinion leaders representing pharma companies, diagnostic companies and other interest groups to share with their insights on this rapidly growing field. 

Speakers

Kenneth J. Bloom, M.D., F.C.A.P.

Chief Medical Officer, Clarient, Inc.

François Ferré, Ph.D

President and CEO of AltheaDx

Laura K. Shawver , PhD

Executive in Residence at 5AM Ventures

Chairman of The Clearity Foundation

James Christensen Ph.D.

Director, Oncology Translational Research, Pfizer

Lyle Arnold, Ph.D.

President and Founder at Aegea Biotechnologies

David Nelson Ph.D.

President and CEO of Epic Sciences

Erik Holmlin Ph.D.

President and CEO of Bionanomatrix

Jian-Bing Fan, Ph.D.

Senior Director, Scientific Research, Illumina

6th Annual SABPA Pacific Forum 2010 - Racing to the top

Date:                     8:30 am – 4:30 pm, Saturday, November 6, 2010
Location:             Institute of Americas, UCSD

For details: http://www.sabpa.org/web/news_details.php?ID=285

Conference Program

8:30 am                Breakfast and Registration

9:00 am                Opening Remarks: SABPA Pacific Forum co-chair

9:10 am                Asia Pacific - How to spot the real opportunities

Gunther Winkler, Ph.D. 
Senior Vice President, Asia Pacific and Global Government Strategy, Biogen Idec

9:40 am                Panel Discussion: Bio-Pharma R&D collaboration around Pacific Rim

Session Leader: Jerry Hefner, Ph.D. Partner, Knobbe Martens Olson & Bear LLP

Bai Lu, Ph.D. VP of GSK in Shanghai

Xiaochuan Wang, Ph.D., CEO, Sundia MediTech Company, Ltd.

Assad J. Kazeminy, Ph.D., Chairman & Founder, Irvine Pharmaceutical Services 

Raymond Price, PhD, MBA, Director of Business Development, GenScript           

10:40 am              Coffee Break and Networking 

11:00 am              Pfizer global Strategy

                                Richard Connell, Ph.D., Vice President of Pfizer External Research Solutions       

11:40 pm              Understanding and Overcoming the Challenges Surrounding International Logistics of Biopharmaceutical Materials

Kevin Xu, General Manager, Biocair China

12:00 pm              Lunch and Networking

1:30 pm                Opening Remarks

1:40 pm                Story about a cross-Pacific CRO marriage: BioDuro and PPD

Lee Babiss, Ph.D., Executive Vice President of Global Laboratory Services, PPD, Inc.

2:10 pm                Panel Discussion:  Deal development, regulatory issues, licensing and Innovation

                                Session Leader: William Looney, Editor-in-Chief from PharmExecutive

                                Li Chen, Ph.D. CEO, Hua Medicine

                                Keiko Mitsunobu, President, UpWell

Dong Liu, Ph.D. Senior Partner, Boss & Young

Michael J. Reilly, Co-founder & CEO, Western States Biopharmaceuticals, Inc.

Yong Qian, Ph.D., CEO, BioMedicure

3:10 pm                Coffee Break and Networking 

3: 30 pm               IP Strategies for Acquiring Multinational's Business in China

Chuck Comey and Peng Chen, Partner, Morrison Foerster

4:00 pm                Shangdong’s business environment and incentive policies

                                Shandong delegation and Shandong BIOasos-Luye Pharma

4:30 pm                Closing Remarks

4:40 pm                Onsite Reception